Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $126.55 USD
Change Today -0.53 / -0.42%
Volume 957.2K
MDVN On Other Exchanges
As of 8:10 PM 03/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

C. Patrick MacHado

AgeTotal Calculated CompensationThis person is connected to 28 board members in 2 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. C. Patrick Machado, also known as Pat, is a Co-Founder of Medivation, Inc. Mr. Machado served as the Chief Financial Officer, Principal Accounting Officer and Chief Business Officer at Medivation, Inc., until April 18, 2014. He served as an Interim Chief Business and Financial Officer at Medivation, Inc., since November 2013. He served as Chief Financial Officer and Senior Vice President of Orion Acquisition Corp. II since December 17, 2004 and also served as its ...

Read Full Background

Corporate Headquarters*

525 Market Street
San Francisco, California 94105

United States

Phone: 415-543-3470
Fax: 415-543-3411

Board Members Memberships*

Director and Member of Audit Committee


Santa Clara University
Santa Clara University
Harvard Law School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$480,400

Stock Options*

All Other Compensation$11,190
Exercisable Options572,105
Exercisable Options Value$28,579,170
Unexercisable Options114,453
Unexercisable Options Value$3,925,230
Total Value of Options$32,504,400
Total Number of Options686,558

Total Compensation*

Total Annual Cash Compensation$1,082,490
Total Short Term Compensation$480,400
Other Long Term Compensation$11,190
Total Calculated Compensation$1,082,490
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDVN:US $126.55 USD -0.53


Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Ariad Pharmaceuticals Inc.
Clay B. Siegall Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Seattle Genetics, Inc.
Shailesh Ayyangar B.V.Fc & A.H., P.G.D.M.Managing Director, Vice President of South Asia- Global Operations, Executive Director and Member of Audit Committee
Sanofi India Limited
Aijaz Tobaccowalla Managing Director, Director, Member of Nomination and Remuneration Committee and Member of Board Administrative Committee
Pfizer Limited
Michael L. Babich Chief Executive Officer, President and Director
INSYS Therapeutics, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIVATION INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at